Advances in medicine and public health have exacerbated global population aging, making dementia a prominent social issue. Despite significant progress, devising methods to slow or halt the progression of dementia—particularly in degenerative conditions—has been challenging. The combined effects of genetic and environmental factors play an important role in the onset of various neurodegenerative diseases. Investigating the interaction between genetic susceptibility and environmental factors, as well as their relationship with neurodegenerative diseases, is crucial for developing personalized intervention measures. Additionally, advancements in body fluid biomarker detection (such as amyloid protein, Tau protein, neuroinflammation-related markers, neuronal NPTX2, SNAP-25.) have enhanced our understanding of the complex pathological biology of cognitive impairment diseases (including Alzheimer's disease, frontotemporal dementia, Lewy body dementia, vascular dementia, etc.) and other neurodegenerative diseases. This has also facilitated the translation of these discoveries into strategies for improving disease management.
In this research topic, we aim to explore recent advances in biological markers associated with neurodegenerative diseases and the impact of potential interventions on these markers. We encourage the submission of thoughtful perspectives on this topic and the elucidation of original research in this field.
This research topic welcomes submissions focused on biomarkers for the identification of effective treatments and early diagnostic models for neurodegenerative diseases. The scope of submissions includes, but is not limited to:
1. Establishing diagnostic or prognostic models for neurodegenerative diseases based on body fluid biomarkers, genetic susceptibility, lifestyle, and other relevant clinic information, to inform treatment and intervention decisions.
2. Research on the pathogenesis of neurodegenerative diseases and the pathological biomarkers reflecting these diseases.
3. Exploring the impact of potential protective measures on biomarkers associated with neurodegenerative diseases.
Advances in medicine and public health have exacerbated global population aging, making dementia a prominent social issue. Despite significant progress, devising methods to slow or halt the progression of dementia—particularly in degenerative conditions—has been challenging. The combined effects of genetic and environmental factors play an important role in the onset of various neurodegenerative diseases. Investigating the interaction between genetic susceptibility and environmental factors, as well as their relationship with neurodegenerative diseases, is crucial for developing personalized intervention measures. Additionally, advancements in body fluid biomarker detection (such as amyloid protein, Tau protein, neuroinflammation-related markers, neuronal NPTX2, SNAP-25.) have enhanced our understanding of the complex pathological biology of cognitive impairment diseases (including Alzheimer's disease, frontotemporal dementia, Lewy body dementia, vascular dementia, etc.) and other neurodegenerative diseases. This has also facilitated the translation of these discoveries into strategies for improving disease management.
In this research topic, we aim to explore recent advances in biological markers associated with neurodegenerative diseases and the impact of potential interventions on these markers. We encourage the submission of thoughtful perspectives on this topic and the elucidation of original research in this field.
This research topic welcomes submissions focused on biomarkers for the identification of effective treatments and early diagnostic models for neurodegenerative diseases. The scope of submissions includes, but is not limited to:
1. Establishing diagnostic or prognostic models for neurodegenerative diseases based on body fluid biomarkers, genetic susceptibility, lifestyle, and other relevant clinic information, to inform treatment and intervention decisions.
2. Research on the pathogenesis of neurodegenerative diseases and the pathological biomarkers reflecting these diseases.
3. Exploring the impact of potential protective measures on biomarkers associated with neurodegenerative diseases.